Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Managing Director - Investments CFP The Summa Group of Oppenheimer & Co. Inc. Asset/Investment Management ...
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Adobe (NASDAQ:ADBE – Get Free Report) had its price target reduced by equities research analysts at Oppenheimer from $560.00 ...
Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...
Director Christopher Nolan's The Odyssey, is gearing up to be his biggest blockbuster yet, as there are many exciting facts ...
Oppenheimer analyst Jay Olson downgraded Sutro Biopharma (STRO) to Perform from Outperform after the company reported Q4 results and announced ...